Literature DB >> 16327593

Hypertrophic response and keloid diathesis: two very different forms of scar.

Andrew Burd1, Lin Huang.   

Abstract

LEARNING
OBJECTIVES: After studying this article, the participant should be able to: 1. Have a greater appreciation of the extent of differences and similarities between keloid and hypertrophic scarring. 2. Have a greater appreciation of the significance of the stage of maturation of a keloid or hypertrophic scar with regard to its morphologic, biochemical, and molecular profile. 3. More critically review basic science research that is based on poorly characterized scar tissue. 4. More critically review clinical studies that are based on poorly characterized scar tissue.
BACKGROUND: Hypertrophic and keloid scars remain extremely challenging, particularly in their variable response to treatment. The understanding of hypertrophic and keloid scarring is evolving from a position where they were regarded as different stages of the same process to the contemporary perspective of two separate entities. This article reviews the differences in the two forms of scarring and discusses the implications for future research.
METHODS: The authors conducted a MEDLINE search of all English language reviews linking key words "hypertrophic," "keloid," and "scarring."
RESULTS: Over the past four decades, there has been considerable clinical and experimental research looking at the biological nature and therapeutic response of keloid and hypertrophic scarring. As more differences are emerging regarding the fundamental biology of the scars, investigators are giving more detailed characterization of their source material. It is evident that even within the broad categories of hypertrophic and keloid scarring there is a heterogenous distribution of pathologic connective tissue matrix biology.
CONCLUSION: Considerable advances have been made in our understanding of the fundamental biology of scarring. As research methodology becomes even more sophisticated, it will be even more crucial to extensively characterize source material, recognizing major differences not only between keloid and hypertrophic scar but also between scars of varying stages of maturation and histomorphological, biochemical, and molecular variations within individual scars.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16327593     DOI: 10.1097/01.prs.0000191977.51206.43

Source DB:  PubMed          Journal:  Plast Reconstr Surg        ISSN: 0032-1052            Impact factor:   4.730


  30 in total

1.  Characteristics of scar margin dynamic with time based on multiphoton microscopy.

Authors:  Xiaoqin Zhu; Shuangmu Zhuo; Liqin Zheng; Xingshan Jiang; Jianxin Chen; Bifang Lin
Journal:  Lasers Med Sci       Date:  2010-10-20       Impact factor: 3.161

2.  Clinical Outcomes Following the Early Application of Multimodal Scar Programs for Facial Incisional Wounds.

Authors:  Joong Min Suh; Seong Hoon Park; Jun Won Lee; Seong Joo Lee; In Suck Suh; Jong Wook Lee; Hii Sun Jeong
Journal:  Aesthetic Plast Surg       Date:  2021-05-10       Impact factor: 2.326

3.  Unfolded protein response regulation in keloid cells.

Authors:  Paris D Butler; Zhen Wang; Daphne P Ly; Michael T Longaker; Albert C Koong; George P Yang
Journal:  J Surg Res       Date:  2009-05-20       Impact factor: 2.192

Review 4.  [Keloid and hypertrophic scar treatment modalities. An update].

Authors:  L K Branski; H O Rennekampff; P M Vogt
Journal:  Chirurg       Date:  2012-09       Impact factor: 0.955

Review 5.  The evidence for the role of transforming growth factor-beta in the formation of abnormal scarring.

Authors:  Richard L Chalmers
Journal:  Int Wound J       Date:  2011-03-30       Impact factor: 3.315

6.  Transplantation of neurospheres derived from bone marrow stromal cells promotes neurological recovery in rats with spinal cord injury.

Authors:  Hidenori Suzuki; Toshihiko Taguchi; Yoshihiko Kato; Tsukasa Kanchiku; Takashi Imagama; Takahiro Yara; Atsushi Moriya; Keiichi Muramatsu; Hiroshi Tanaka; Toshikazu Gondo
Journal:  Med Mol Morphol       Date:  2011-09-16       Impact factor: 2.309

Review 7.  Low-dose enalapril in the treatment of surgical cutaneous hypertrophic scar and keloid--two case reports and literature review.

Authors:  Silvai Iannello; Paolina Milazzo; Fabio Bordonaro; Francesco Belfiore
Journal:  MedGenMed       Date:  2006-12-20

8.  A new technology for reducing anastomotic fistula in the neck after esophageal cancer surgery.

Authors:  Ya-Nan Song; Yu Qi; Chun-Yang Zhang; Yin-Liang Sheng; Kai Wu; Sen-Lin Zhu; Lu Han; Ting-Ting Shan; Guan-Chao Ye; Qing-Yi Zhang; Yan-Li Chen; Jin-Wei Chen; Ya-Fei Liu; Lu-Bing Gao; Yang Yang; Zhan-Feng He; Deng-Yan Zhu; Dong-Lei Liu; Feng-Biao Wen; Tian-Liang Zheng; Ji-Lun Li; Song Zhao
Journal:  J Thorac Dis       Date:  2019-07       Impact factor: 2.895

9.  Advanced skin, scar and wound care centre for children: A new era of care.

Authors:  Andrew Burd; Lin Huang
Journal:  Indian J Plast Surg       Date:  2012-05

10.  Description of familial keloids in five pedigrees: evidence for autosomal dominant inheritance and phenotypic heterogeneity.

Authors:  Jason A Clark; Maria L Turner; Lillian Howard; Horia Stanescu; Robert Kleta; Jeffrey B Kopp
Journal:  BMC Dermatol       Date:  2009-07-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.